Literature DB >> 25894765

The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.

Yi-Qun Kuang1, Hong-Liang Liu, Yong-Tang Zheng.   

Abstract

During the long-term evolutionary history, the interaction between virus and host has driven the first-line barrier, innate immunity, to invading pathogens. Innate immune factor TRIM5α and host peptidyl-prolyl cis-trans isomerase Cyclophilin A are two key players in the interaction between HIV-1 and host. Interestingly, Cyclophilin A is retrotransposed into the critical host gene, TRIM5, locus via LINE-1 element in some primate species including New World monkeys and Old World monkeys. This review aims to comprehensively discuss the sensing and immune activation procedures of TRIM5α innate signaling pathway through Cyclophilin A. It will then present the production of TRIMCyp chimeric gene and the different fusion patterns in primates. Finally, it will summarize the distinct restriction activity of TRIMCyp from different primates and explain the current understanding on the innate immune mechanisms involved in the early phase of the viral life cycle during HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894765     DOI: 10.1007/s00430-015-0417-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  82 in total

1.  The ability of multimerized cyclophilin A to restrict retrovirus infection.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Wen Yuan; Darwin F Yeung; Xing Li; Byeongwoon Song; Joseph Sodroski
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

2.  Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.

Authors:  Elena Sokolskaja; Lionel Berthoux; Jeremy Luban
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Evolution of cyclophilin A and TRIMCyp retrotransposition in New World primates.

Authors:  Ieda P Ribeiro; Albert N Menezes; Miguel A M Moreira; Cibele R Bonvicino; Héctor N Seuánez; Marcelo A Soares
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 5.  TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.

Authors:  Markus G Grütter; Jeremy Luban
Journal:  Curr Opin Virol       Date:  2012-03-05       Impact factor: 7.090

6.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

7.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

8.  Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.

Authors:  Cesar A Virgen; Zerina Kratovac; Paul D Bieniasz; Theodora Hatziioannou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  2 in total

1.  Rhesus monkey TRIM5α protein SPRY domain contributes to AP-1 activation.

Authors:  Lei Na; Yan-Dong Tang; Cuihui Wang; Cong Liu; Xiaojun Wang
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

2.  To TRIM the Immunity: From Innate to Adaptive Immunity.

Authors:  Wenyong Yang; Zhiwen Gu; Huiyuan Zhang; Hongbo Hu
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.